A 14 | 合法醫療器材資訊網

Read More

由 林俊谷 著作 · 被引用 1 次 — 幽門螺旋桿菌（Helicobacter pylori）感染是. 引起胃潰瘍、十二指腸潰瘍、胃腺癌和胃 ... pump inhibitor based triple therapy for Helicobacter pylori eradication. Read More

由 JT Lamont 著作 — There are also limited data on H. pylori antibiotic resistance rates to guide therapy. The treatment regimen that is selected must consider ... Read More

2021年7月8日 — Triple therapy Triple therapy for Helicobacter pylori infection consists of the following: Proton pump inhibitor (PPI) (omeprazole 20 mg BID ... Read More

2020年12月9日 — Clarithromycin 500 mg BID (first-line and continues to be recommended in areas where H pylori clarithromycin resistance is less than 15% and in ... Read More

由 L Myran 著作 · 2018 · 被引用 3 次 — Nonbismuth quadruple therapy (i.e., concomitant) for 10 to 14 days (the Toronto Consensus strongly recommends 14 days) is another first-line ... Read More

由 A Randel 著作 · 2018 · 被引用 6 次 — Bismuth quadruple therapy consists of a PPI, bismuth, tetracycline, and a nitroimidazole for 10 to 14 days. It may be a particularly good option ... Read More

由 YI Chen 著作 · 2015 · 被引用 13 次 — Our study demonstrated that a 14-day course of standard triple therapy for H pylori with lansoprazole, amoxicillin and clarithromycin was superior to a 10-day ... Read More

由 WD Chey 著作 · 2017 · 被引用 852 次 — pyloriisolates is known to be low. Most patients will be better served by first-line treatment with bismuth quadruple therapy or concomitant therapy consisting ... Read More